Home
Telix Pharmaceuticals Limited
First Patient Dosed in Ph III ProstACT GLOBAL Therapy Study
Business
Nov 13 2023
4 min read

First Patient Dosed in Ph III ProstACT GLOBAL Therapy Study

news images

Telix Pharmaceuticals Ltd has released a press release.

View Attachment

Original text
Rate this translation
Your feedback will be used to help improve Google Translate